Show simple item record

dc.contributor.authorEtienne, Carissa F.
dc.contributor.authorCaliff, Robert
dc.date.accessioned2016-06-20T23:23:51Z
dc.date.available2016-06-20T23:23:51Z
dc.date.issued2016-05
dc.identifier.urihttps://iris.paho.org/handle/10665.2/28533
dc.description.abstractHealth regulation is regarded as one of public health’s basic functions. Effective regulation of medicines promotes and protects the public’s health by guaranteeing medicines quality, safety, and efficacy; promoting the adequate manufacture, storage, and distribution of medicines; facilitating the fight against substandard, spurious, falsely labeled, falsified, or counterfeit medical products; providing the necessary information to health professionals and patients so they can use medicines rationally; and ensuring that access to medicines is not hindered by inefficient regulatory frameworks. Developing a strong national regulatory system is, therefore, a critical component of a national health system. In this context, we are pleased to present the first ever special issue of the Pan American Journal of Public Health to focus on strengthening of regulatory systems for medicines and other technologies. This special issue is an expression of the resolve of the governments of the Americas in implementing the Pan American Health Organization Directing Council Resolution CD50.R9 (2010) “Strengthening National Regulatory Authorities for Medicines and Biologicals,” and more recently of the Member States of the World Health Organization in the adoption of resolution WHA67.20 (2014), “Regulatory system strengthening for medical products.”...The journal brings together articles from regulatory experts within the Region of the Americas as well as from global experts, who bring an array of experiences to the fore. They present the essential underpinning of science and regulation that bring life-saving and innovative products to the marketplace; analysis of key contributions from international fora and public-private coalitions that can add to regulatory science and the development of good regulatory practices; and the ever-evolving challenges that regulators face to build inter-linked and convergent regulatory systems within the context of limited capacity, human and financial resources, nationally and globally.en_US
dc.language.isoenes_ES
dc.relation.ispartofseriesRev Panam Salud Publica;39(5), may 2016es_ES
dc.subjectLegislation, Druges_ES
dc.subjectDrug and Narcotic Controlen_US
dc.subjectGovernment Regulationes_ES
dc.subjectRegulationses_ES
dc.subjectInternational Cooperationes_ES
dc.subjectHealth Surveillanceen_US
dc.subjectNational Health Systemsen_US
dc.titleStrengthening of regulatory systems for medicines in the Americasen_US
dc.title.alternativeFortalecimiento de los sistemas regulatorios de los medicamentos en la Región de las Américases_ES
dc.typeJournal articlesen_US
dc.rights.holderPan American Health Organizationen_US
paho.articletypeEditorialses_ES
paho.source.centercodeUS1.1es_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record